Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
暂无分享,去创建一个
D. M. van der Heijde | R. Landewé | P. Mease | I. McInnes | P. Conaghan | H. Richards | L. Pricop | G. Ligozio | S. Mpofu